[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1007081, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 508886, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew W. Gengos", "age": 60, "title": "CFO & Head of Corporate Development", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caryn Gordon McDowell J.D.", "age": 54, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Robin  Andrulevich", "age": 58, "title": "Chief People Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Sieminski", "title": "Senior Vice President of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Kanter", "title": "Senior VP of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.76, "open": 6.77, "dayLow": 6.59, "dayHigh": 7.07, "regularMarketPreviousClose": 6.76, "regularMarketOpen": 6.77, "regularMarketDayLow": 6.59, "regularMarketDayHigh": 7.07, "payoutRatio": 0.0, "beta": -0.063, "forwardPE": -4.9856114, "volume": 1289137, "regularMarketVolume": 1289137, "averageVolume": 1003193, "averageVolume10days": 1250380, "averageDailyVolume10Day": 1250380, "bid": 6.9, "ask": 6.97, "bidSize": 1, "askSize": 1, "marketCap": 606451200, "fiftyTwoWeekLow": 1.865, "fiftyTwoWeekHigh": 11.4, "fiftyDayAverage": 5.2682, "twoHundredDayAverage": 4.551425, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 292139552, "profitMargins": 0.0, "floatShares": 57156091, "sharesOutstanding": 87511000, "sharesShort": 6729143, "sharesShortPriorMonth": 6115009, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0769, "heldPercentInsiders": 0.00298, "heldPercentInstitutions": 0.99081004, "shortRatio": 7.07, "shortPercentOfFloat": 0.077, "impliedSharesOutstanding": 87511000, "bookValue": 3.49, "priceToBook": 1.9856733, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -91745000, "trailingEps": -1.03, "forwardEps": -1.39, "enterpriseToEbitda": -2.77, "52WeekChange": -0.1630435, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 6.93, "targetHighPrice": 34.0, "targetLowPrice": 14.0, "targetMeanPrice": 20.0, "targetMedianPrice": 18.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 315444992, "totalCashPerShare": 3.605, "ebitda": -105483000, "totalDebt": 1133000, "quickRatio": 24.427, "currentRatio": 24.698, "debtToEquity": 0.371, "returnOnAssets": -0.23966, "returnOnEquity": -0.35022998, "freeCashflow": -48282248, "operatingCashflow": -74359000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 2.51479, "regularMarketPrice": 6.93, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755903706, "regularMarketTime": 1755892801, "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "shortName": "Terns Pharmaceuticals, Inc.", "longName": "Terns Pharmaceuticals, Inc.", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "postMarketChangePercent": 2.1645036, "postMarketPrice": 7.08, "postMarketChange": 0.1500001, "regularMarketChange": 0.17, "regularMarketDayRange": "6.59 - 7.07", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1003193, "fiftyTwoWeekLowChange": 5.0649996, "fiftyTwoWeekLowChangePercent": 2.7158175, "fiftyTwoWeekRange": "1.865 - 11.4", "fiftyTwoWeekHighChange": -4.47, "fiftyTwoWeekHighChangePercent": -0.39210525, "fiftyTwoWeekChangePercent": -16.30435, "earningsTimestampStart": 1754424000, "earningsTimestampEnd": 1754424000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.03, "epsForward": -1.39, "epsCurrentYear": -1.11978, "priceEpsCurrentYear": -6.188716, "fiftyDayAverageChange": 1.6617999, "fiftyDayAverageChangePercent": 0.3154398, "twoHundredDayAverageChange": 2.3785748, "twoHundredDayAverageChangePercent": 0.52260005, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.4 - Strong Buy", "esgPopulated": false, "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]